Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Colorectal Neoplasms 442Rectal Neoplasms 209Colonic Neoplasms 202Pancreatic Neoplasms 133Stomach Neoplasms 117Neoplasm Metastasis 86Esophageal Neoplasms 57Carcinoma, Hepatocellular 41Adenocarcinoma Of Esophagus 37Neoplasms 36Cholangiocarcinoma 27Biliary Tract Neoplasms 23Gastrointestinal Neoplasms 20Gallbladder Neoplasms 20Adenocarcinoma 19Carcinoma, Non-Small-Cell Lung 16Esophageal Squamous Cell Carcinoma 15Liver Neoplasms 14Bile Duct Neoplasms 14Digestive System Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Colorectal Cancer Metastatic 8Appendiceal Neoplasms 7Peritoneal Neoplasms 6Ovarian Neoplasms 6Intestinal Neoplasms 6Carcinoma 6Breast Neoplasms 6Lung Neoplasms 5Carcinoma, Renal Cell 5

Interventions

folfirinox 1Taxes 1Oxaliplatin 1Leucovorin 1Irinotecan 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Basal Cell × Leucovorin × Gastrointestinal × Clear all
NCT06483555 2026-04-23

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
104 enrolled
DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡